Drug & supplement interaction

Bifidobacterium Longum + Clobetasol Propionate

Clobetasol Propionate brand names: Impoyz, Impeklo.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Bifidobacterium Longum and Clobetasol Propionate in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Bifidobacterium Longum and Clobetasol Propionate

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Clobetasol Propionate and Bifidobacterium Longum in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Bifidobacterium Longum safety at a glance

Bifidobacterium Lo... overall Use caution Generally well tolerated in healthy people, but caution is needed for those who are seriously ill or immune-compromised.
Pregnancy Possibly Safe When used orally and appropriately, short-term. A combination of Bifidobacterium longum and Lacticaseibacillus rhamnosus has been used with apparent safety thro... Read the full pregnancy detail
Breastfeeding Possibly Safe When used orally and appropriately, short-term. A combination of Bifidobacterium longum and Lacticaseibacillus rhamnosus has been used with apparent safety thro... Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Clobetasol Propionate and Bifidobacterium Longum? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Clobetasol Propionate

Interactions in our licensed database are recorded against drug classes, not just single drug names. Clobetasol Propionate is filed under a single classification — topical drugs. Bifidobacterium Longum has documented interactions with 1 drug class — the most serious being antibiotic drugs (moderate) — and none of Clobetasol Propionate’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Bifidobacterium Longum Does Interact With Other Medications

Bifidobacterium Longum has 182 moderate known drug interactions in our database — Clobetasol Propionate isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Bifidobacterium Longum

Covers the 2,830 medications we’ve checked against Bifidobacterium Longum. Pick one to open its full report.

What to actually watch for

What Bifidobacterium Longum Itself Has Been Linked To

This is not an interaction — nothing below involves Clobetasol Propionate. It is the side-effect record for Bifidobacterium Longum on its own, from the licensed Natural Medicines monograph. If something new turns up after you add Bifidobacterium Longum, this list is the first place to look. One entry is worth acting on rather than waiting out — marked below.

  • A higher chance of infection Worth acting on Additional detail

    “There have been rare cases of Bifidobacterium bacteremia in critically ill infant and adult patients. Various cases of Bifidobacterium longum bacteremia, sometimes presenting as sepsis, have occurred in preterm infants using probiotics.”

    Bifidobacterium Longum · Natural Medicines adverse-effect record, reported in cancer.

    6 sources cited
    1. 102416. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
    2. 107599. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
    3. 111610. US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
    4. 111612. Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. PubMed
    5. 111850. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.
    6. 111852. Bertelli C, Pillonel T, Torregrossa A, et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015;60(6):924-7. PubMed
  • Bloating or gas / Stomach upset / Constipation Additional detail

    “When taken orally, abdominal discomfort, pain, and distension have been reported rarely. Flatulence has been reported rarely with Bifidobacterium longum when used alone or in combination with other species of probiotics. Other rare gastrointestinal side effects have included constipation and gastrointestinal motor disorder.”

    Bifidobacterium Longum · Natural Medicines adverse-effect record, reported in constipation.

    4 sources cited
    1. 111773. Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022;28(7):732-744.
    2. 111847. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52(11) PubMed
    3. 111856. Sangkanjanavanich S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, Boonpiyathad T. Bifidobacterium infantis 35624 efficacy in patients with uncontrolled asthma: A randomized placebo-controlled trial. Ann Allergy Asthma Immunol 2022;129(6):790-792. PubMed
    4. 107520. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  • Cough Additional detail

    “When taken orally, a dry cough has been reported by a single patient in a clinical trial.”

    Bifidobacterium Longum · Natural Medicines adverse-effect record, reported in cough.

    1 source cited
    1. 111851. Tamaki H, Nakase H, Inoue S, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc 2016;28(1):67-74.

Everything above comes from the Natural Medicines adverse-effect record for Bifidobacterium Longum — expand a row for the licensed statement it rests on. We read the ADVERSE REACTIONS section of Clobetasol Propionate’s FDA label too, and the two lists don’t meaningfully overlap — which is why no Clobetasol Propionate column appears here.

Special populations

Bifidobacterium Longum in Pregnancy & Breastfeeding

Pregnancy And Lactation Possibly Safe

When used orally and appropriately, short-term. A combination of Bifidobacterium longum and Lacticaseibacillus rhamnosus has been used with apparent safety throughout pregnancy. A combination of B. longum BB536 and Bifidobacterium breve M-16V has been used with apparent safety from about 4 weeks before the expected due date until delivery. Also, a combination of B. longum and Lacticaseibacillus paracasei has been used with apparent safety from 2 months prior to delivery until 2 months after delivery during lactation.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Everything else you take

See Every Supplement That Interacts With Clobetasol Propionate

This page covers Bifidobacterium Longum only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Clobetasol Propionate page lists 3 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Dimethylsulfoxide (dmso) (moderate), Turpentine Oil (moderate) and Alchemilla (minor).

By severity: 2 moderate · 1 minor.

From our pharmacist’s overview on the Clobetasol Propionate page

“Clobetasol propionate (Impoyz, Impeklo) is one of the strongest steroid creams available, and only three supplement ingredients are known to interact with it, all of them things you might also put on your skin. None rate major.”

Reviewed by 2 · Jul 18, 2026

Open the Clobetasol Propionate interaction page

One more smart check

Taking Bifidobacterium Longum as Part of a Dietary Supplement Product? Check It for Interactions

We hold 3,189 real supplement products containing Bifidobacterium Longum, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Bifidobacterium Longum. Even though Bifidobacterium Longum itself has no known interaction with Clobetasol Propionate, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Bifidobacterium Longum and Clobetasol Propionate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Bifidobacterium Longum
Top 10%

#92 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Clobetasol Propionate
Top 25%

#477 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Bifidobacterium Longum reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Bifidobacterium Longum and Clobetasol Propionate records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Bifidobacterium Longum

What is Bifidobacterium Longum?

  • Digestive health and regularity
  • Irritable bowel syndrome (IBS)
  • Diarrhea (including antibiotic-related)
  • Immune support
  • Mood and stress (gut-brain axis)

Bifidobacterium longum is a 'friendly' bacterium found naturally in the human gut and used as a probiotic. It is generally well tolerated and is most studied for digestive issues, though evidence for many uses is still limited or mixed. Talk to your pharmacist or doctor before using it, especially if you have a weakened immune system.

Bifidobacterium longum · Bifidobacteriaceae · Live bacterial cells (probiotic) · Capsules, tablets, powders, sachets, fermented foods, and multi-strain probiotic blends

An interaction check asks whether these two react with each other — it does not ask whether Bifidobacterium Longum is a good idea for someone in your situation. Here is what our Bifidobacterium Longum record says about it on its own.

Bifidobacterium Longum: dosing

There is no single established 'correct' dose for Bifidobacterium longum. Probiotic doses are usually measured in colony-forming units (CFU), and products vary widely in how many CFU they contain and which strains they include.The best approach is to follow the directions on your specific product's label. Keep the product stored as directed (some need refrigeration) to keep the bacteria alive and effective.

From our Bifidobacterium Longum monograph — the full record covers uses, side effects and every documented interaction.

Read the full Bifidobacterium Longum monograph & all interactions
Medication

About Clobetasol Propionate

Most-Reported Side Effects for Clobetasol Propionate

From FAERS, the FDA’s public side-effect reporting system (10,471 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Pruritus 925 reports
Rash 667 reports
Psoriasis 550 reports
Fatigue 512 reports
Headache 493 reports
Keep checking

Other Drugs & Bifidobacterium Longum

Browse every other medication we’ve checked against Bifidobacterium Longum — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
182Moderate
0Minor
2,647No known interaction
Moderate

182 interactions

Showing 60 of 182 moderate interactions — see all 182 on the Bifidobacterium Longum page.

No interaction 2,647 drugs checked — show the list
Evidence & sources

Bifidobacterium Longum References

The 21 references that drive our Bifidobacterium Longum monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. J Clin Microbiol 1999;37:1227-8.
  2. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  3. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  4. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130(6):1355-60. PubMed
  5. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  6. Pellonperä O, Vahlberg T, Mokkala K, et al. Weight gain and body composition during pregnancy: a randomised pilot trial with probiotics and/or fish oil. Br J Nutr. 2020 Nov 4:1-11. PubMed
  7. Pellonperä O, Mokkala K, Houttu N, et al. Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: A randomized, placebo-controlled, double-blind clinical trial PubMed
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
  10. Enomoto T, Sowa M, Nishimori K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int 2014;63(4):575-85. PubMed
  11. US Food and Drug Administration (FDA). Dear Healthcare Provider Letter: Warning Regarding Use of Probiotics in Preterm Infants. September 2023. Available at: https://www.fda.gov/media/172606/download?attachment. Accessed November 1, 2023.
  12. Pillai A, Tan J, Paquette V, Panczuk J. Does probiotic bacteremia in premature infants impact clinically relevant outcomes? A case report and updated review of literature. Clin Nutr ESPEN. 2020;39:255-259. PubMed
  13. Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022;28(7):732-744.
  14. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52(11) PubMed
  15. Zbinden A, Zbinden R, Berger C, Arlettaz R. Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 2015;107(1):56-9.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Bifidobacterium Longum and Clobetasol Propionate Together: Common Questions

Is it safe to take Bifidobacterium Longum with Clobetasol Propionate?
We do not list a known interaction between Bifidobacterium Longum and Clobetasol Propionate. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the Bifidobacterium Longum and Clobetasol Propionate combination checked?
Interactions in our licensed database are recorded against drug classes. Clobetasol Propionate is filed under 1 classification, and Bifidobacterium Longum has documented interactions with 1 drug class — none of Clobetasol Propionate's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Bifidobacterium Longum interact with any other medications?
Yes. Bifidobacterium Longum has 182 documented drug interactions in our database — Clobetasol Propionate is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Clobetasol Propionate interact with any supplements?
Yes. Clobetasol Propionate has documented interactions with 3 supplements in our database — Bifidobacterium Longum is not one of them. The Clobetasol Propionate interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Clobetasol Propionate and Bifidobacterium Longum?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.